Circadian variation in portal pressure: Appropriate use of non-selective beta blockers in the prevention of variceal bleed

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The circadian variation in some biologic functions may have clinical, fiscal and therapeutic implications. The authors discuss circadian variation in portal pressure in cirrhotic patients and nocturnal occurrence of bleeding from varices in these patients. The pathogenesis of the diurnal variation in portal pressure is presented. The authors submit the hypothesis that an optimal dosing regimen for non-selective beta blocker therapy in the prevention of variceal bleed must include an evening dose of beta blocker medication. In studies reporting comparative efficacy of beta blocker therapy with other modalities in the prevention of variceal bleeding, the optimal dosing schedule for beta blocker therapy must be emphasized.

Original languageEnglish (US)
Pages (from-to)423-425
Number of pages3
JournalMedical Hypotheses
Volume57
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Portal Pressure
Hemorrhage
Varicose Veins
Therapeutics
Appointments and Schedules

ASJC Scopus subject areas

  • Developmental Biology
  • Medicine(all)
  • Drug Discovery

Cite this

@article{9f00135f57614507883f867aa18e580d,
title = "Circadian variation in portal pressure: Appropriate use of non-selective beta blockers in the prevention of variceal bleed",
abstract = "The circadian variation in some biologic functions may have clinical, fiscal and therapeutic implications. The authors discuss circadian variation in portal pressure in cirrhotic patients and nocturnal occurrence of bleeding from varices in these patients. The pathogenesis of the diurnal variation in portal pressure is presented. The authors submit the hypothesis that an optimal dosing regimen for non-selective beta blocker therapy in the prevention of variceal bleed must include an evening dose of beta blocker medication. In studies reporting comparative efficacy of beta blocker therapy with other modalities in the prevention of variceal bleeding, the optimal dosing schedule for beta blocker therapy must be emphasized.",
author = "Mann, {N. S.} and Leung, {J. W.}",
year = "2001",
doi = "10.1054/mehy.2001.1323",
language = "English (US)",
volume = "57",
pages = "423--425",
journal = "Medical Hypotheses",
issn = "0306-9877",
publisher = "Churchill Livingstone",
number = "4",

}

TY - JOUR

T1 - Circadian variation in portal pressure

T2 - Appropriate use of non-selective beta blockers in the prevention of variceal bleed

AU - Mann, N. S.

AU - Leung, J. W.

PY - 2001

Y1 - 2001

N2 - The circadian variation in some biologic functions may have clinical, fiscal and therapeutic implications. The authors discuss circadian variation in portal pressure in cirrhotic patients and nocturnal occurrence of bleeding from varices in these patients. The pathogenesis of the diurnal variation in portal pressure is presented. The authors submit the hypothesis that an optimal dosing regimen for non-selective beta blocker therapy in the prevention of variceal bleed must include an evening dose of beta blocker medication. In studies reporting comparative efficacy of beta blocker therapy with other modalities in the prevention of variceal bleeding, the optimal dosing schedule for beta blocker therapy must be emphasized.

AB - The circadian variation in some biologic functions may have clinical, fiscal and therapeutic implications. The authors discuss circadian variation in portal pressure in cirrhotic patients and nocturnal occurrence of bleeding from varices in these patients. The pathogenesis of the diurnal variation in portal pressure is presented. The authors submit the hypothesis that an optimal dosing regimen for non-selective beta blocker therapy in the prevention of variceal bleed must include an evening dose of beta blocker medication. In studies reporting comparative efficacy of beta blocker therapy with other modalities in the prevention of variceal bleeding, the optimal dosing schedule for beta blocker therapy must be emphasized.

UR - http://www.scopus.com/inward/record.url?scp=0035168314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035168314&partnerID=8YFLogxK

U2 - 10.1054/mehy.2001.1323

DO - 10.1054/mehy.2001.1323

M3 - Article

C2 - 11601861

AN - SCOPUS:0035168314

VL - 57

SP - 423

EP - 425

JO - Medical Hypotheses

JF - Medical Hypotheses

SN - 0306-9877

IS - 4

ER -